Patient safety revisited: reliability is paramount

Anesthesia and Analgesia

Volumn 108, Issue 3, 2009, Pages 702-703

  Brull, Sorin J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; ROCURONIUM; SUGAMMADEX; SUXAMETHONIUM; CENTRAL MUSCLE RELAXANT; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR DEPOLARIZING AGENT;

CONVALESCENCE; DRUG CHOICE; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; LUNG CLEARANCE; MUSCLE TWITCH; NERVE BLOCK; NEUROMUSCULAR FUNCTION; PARALYSIS; PATIENT SAFETY; PRIORITY JOURNAL; RELIABILITY; ANESTHESIA; DRUG ANTAGONISM; NOTE; SAFETY;

ANESTHESIA; GAMMA-CYCLODEXTRINS; HUMANS; MUSCLE RELAXANTS, CENTRAL; NEUROMUSCULAR DEPOLARIZING AGENTS; SAFETY; SUCCINYLCHOLINE;

EID: 61949393077     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181957db3     Document Type: Editorial

References (6)

1. Miller R. Will succinylcholine ever disappear? Anesth Analg 2004;98:1674-5
2. Savarese JJ, Kitz RJ. Does clinical anesthesia need new neuromuscular blocking agents? Anesthesiology 1975;42:236-9
3. Katz RL, Ryan JF. The neuromuscular effects of suxamethonium in man. Br J Anaesth 1969;41:381-90
4. Kopman AF, Zhaku B, Lai KS. The "intubating dose" of succinylcholine. Anesthesiology 2003;99:1050-4
5. White PF, Tufanogullari B, Sacan O, Pavlin EG, Viegas OJ, Minkowitz HS, Hudson ME. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex. Anesth Analg 2009;108:846-51
6. Puhringer FK, Rex C, Sielenkamper AW, Claudius C, Larsen PB, Prins ME, Eikermann M, Khuenl-Brady KS. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology 2008;109:188-97